HC Wainwright Analysts Boost Earnings Estimates for CGTX
Cognition Therapeutics, Inc. (NASDAQ:CGTX – Free Report) – Investment analysts at HC Wainwright lifted their Q3 2025 earnings per share estimates for Cognition Therapeutics in a research note issued on Tuesday, May 27th. HC Wainwright analyst R. Selvaraju now expects that the company will earn ($0.06) per share for the quarter, up from their prior […]
Cognition Therapeutics, Inc. (NASDAQ:CGTX – Free Report) – Investment analysts at HC Wainwright lifted their Q3 2025 earnings per share estimates for Cognition Therapeutics in a research note issued on Tuesday, May 27th. HC Wainwright analyst R. Selvaraju now expects that the company will earn ($0.06) per share for the quarter, up from their prior […]
